Friday, July 25, 2014

J&J 3Q net rises slightly on higher medicine sales

October 15. 2013 8:36AM
Associated Press

Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle

(AP) Health care giant Johnson & Johnson says third-quarter profit edged up as a big jump in prescription drug sales and lower research spending made up for slumping sales of medical devices.

Its results beat Wall Street estimates and its shares rose 1.3 percent to $91 in premarket trading.

The maker of baby shampoo, joint replacements and drugs for immune disorders says net income was $2.98 billion, or $1.04 per share, up from $2.97 billion, or $1.05 per share, a year earlier.

Excluding one-time charges, it earned $1.36 per share. That was 4 cents per share better than analysts expected.

The company, based in New Brunswick, N.J., says revenue totaled $17.58 billion, up 3 percent. Analysts expected $17.43 billion.

J&J nudged up its profit forecast to $5.44 to $5.49 per share. Analysts expect $5.46 per share.

Associated Press

comments powered by Disqus Commenting Guidelines
Mortgage Minute

Search for New & Used Cars

Used New All

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals

Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds